Thursday, 7 July, 2022
HomeNews UpdateNew device screens for HIV among Mozambique infants

New device screens for HIV among Mozambique infants

[b]Alere Inc[/b] has announced a study demonstrating the viability of accurate and rapid HIV screening among 827 infants at the point of care (POC), reports [s]The Wall Street Journal[/s]. The study was conducted in five clinics in [b]Maputo, Mozambique[/b], with the prototype of Alere's new POC nucleic acid test. Commenting on the study results, Dr Landon Myer of the [b]School of Public Health, University of Cape Town[/b], said: ‘The ability to provide a definitive HIV test result in less than 60 minutes changes how we relate to our patients and how patientsexperience the healthcare system. If approved, this test will allow us to immediately initiate ART in HIV-positive infants, and reduce morbidity and mortality in this vulnerable population.’

[link url=]Full report in The Wall Street Journal[/link]
[link url=]Journal of Acquired Immune Deficiency Syndromes abstract[/link]

MedicalBrief — our free weekly e-newsletter

We'd appeciate as much information as possible, however only an email address is required.